Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

OncoGenex Pharmaceuticals Company Profile (NASDAQ:OGXI)

Consensus Ratings for OncoGenex Pharmaceuticals (NASDAQ:OGXI) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $6.13 (169.82% upside)

Analysts' Ratings History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/30/2015Needham & Company LLCLower Price TargetBuy$14.00 -> $7.00ViewTweet This Rating  Share This Rating on StockTwits
12/30/2014William BlairSet Price TargetBuy$8.00 -> $4.00ViewTweet This Rating  Share This Rating on StockTwits
12/19/2014Needham & Company LLCSet Price TargetBuy$14.00ViewTweet This Rating  Share This Rating on StockTwits
4/29/2014Stifel NicolausLower Price TargetBuy$21.00 -> $9.00ViewTweet This Rating  Share This Rating on StockTwits
4/29/2014RBC CapitalDowngradeOutperform -> Sector Perform$19.00 -> $4.50ViewTweet This Rating  Share This Rating on StockTwits
4/28/2014Needham & Company LLCDowngradeStrong-Buy -> Buy$30.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2014CRT CapitalInitiated CoverageBuy$20.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013Stifel NicolausLower Price TargetBuy$26.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
10/28/2013Needham & Company LLCUpgradeBuy -> Strong-Buy$20.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
8/9/2013Stifel NicolausLower Price TargetBuy$30.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2013RBC CapitalBoost Price TargetOutperform$17.00 -> $19.00ViewTweet This Rating  Share This Rating on StockTwits
5/3/2013Bloom BurtonBoost Price TargetBuy$20.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/19/2013 forward)